Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

NTLA Intellia Therapeutics Inc

21,4789

-0,6211 (-2,81%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Intellia Therapeutics Charts.

Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Intellia Therapeutics Charts.

News Intellia Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Donnerstag 9 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
Donnerstag 2 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
Montag 29 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 26 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Intellia Therapeutics Inc News-Artikel

GraniteShares 2X Long AM...

Amundi Index Solutions

First Trust Vest US Equi...

TCTM Kids IT Education

Prime Meta Token

Imperial Brands

Australian Silica Quartz

Deep Value Dividend Oppo...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen